Equities

Hetzer Medical Indonesia Tbk PT

MEDS:JKT

Hetzer Medical Indonesia Tbk PT

Actions
Health CareMedical Equipment and Services
  • Price (IDR)50.00
  • Today's Change0.00 / 0.00%
  • Shares traded3.50k
  • 1 Year change0.00%
  • Beta--
Data delayed at least 10 minutes, as of Nov 15 2024 07:25 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of IDR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments6665,3621,401
Total Receivables, Net6,2861,5013,190
Total Inventory8,4907,3409,146
Prepaid expenses8,07923,1881,158
Other current assets, total------
Total current assets23,52137,39014,895
Property, plant & equipment, net52,11143,52335,040
Goodwill, net------
Intangibles, net------
Long term investments1,445----
Note receivable - long term------
Other long term assets------
Total assets77,12580,92749,981
LIABILITIES
Accounts payable8751,6272,431
Accrued expenses------
Notes payable/short-term debt45227488
Current portion long-term debt/capital leases2,2292,0791,939
Other current liabilities, total2,7731633,337
Total current liabilities6,3304,1437,795
Total long term debt5,3107,6829,261
Total debt7,99110,03511,288
Deferred income tax------
Minority interest------
Other liabilities, total329316461
Total liabilities11,96912,14017,517
SHAREHOLDERS EQUITY
Common stock31,25031,25025,000
Additional paid-in capital29,86729,867--
Retained earnings (accumulated deficit)4,3577,9287,691
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(319)(258)(227)
Total equity65,15668,78732,463
Total liabilities & shareholders' equity77,12580,92749,981
Total common shares outstanding1,5631,5631,563
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.